News about Engineering

AlidaBio Launches EpiPlex Duo-Mod for Dual m6A-Inosine Mapping with RNA Expression Profiling

AlidaBio Launches EpiPlex Duo-Mod for Dual m6A-Inosine Mapping with RNA Expression Profiling

AlidaBio has launched the EpiPlex Duo-Mod Service, offering simultaneous m6A and inosine mapping with integrated gene expression profiling, enabling researchers to compare modification patterns and transcriptional changes from a single RNA input.

Engineering | 06/12/2025 | By Dineshwori

Continuous Tableting Breakthrough: GEA and Hovione Introduce ConsiGma CDC Flex System

Continuous Tableting Breakthrough: GEA and Hovione Introduce ConsiGma CDC Flex System

GEA and Hovione have expanded their long-standing partnership with the launch of the ConsiGma CDC Flex system — a next-generation continuous direct compression (CDC) platform designed to deliver greater flexibility, simplicity and cost-efficiency in the development and production of oral solid dosage forms.

Engineering | 04/12/2025 | By Dineshwori

TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen

TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen

Kytopen has strengthened its European footprint with a new partnership granting TQ Therapeutics on-site access to its non-viral Flowfect Tx cellular engineering platform. The collaboration will support integration of the technology into TQ’s CELLfinity platform.

Engineering | 04/12/2025 | By Dineshwori

Elekta Launches Evo Linear Accelerator in India

Elekta Launches Evo Linear Accelerator in India

Elekta has introduced its latest linear accelerator (linac), Evo, to the Indian market, expanding its global rollout after introductions in Europe and other regions.

Engineering | 01/12/2025 | By Dineshwori 148

Granules launches peptide and particle-engineering centres at IIT Hyderabad

Granules launches peptide and particle-engineering centres at IIT Hyderabad

Granules India Limited has inaugurated two new Centres of Excellence at IIT Hyderabad’s Technology Research Park, strengthening its capabilities in advanced pharmaceutical research and development.

Engineering | 01/12/2025 | By Darshana

L&T Technology Services Develops NVIDIA AI-Powered Digital Twin Platform for Respiratory Diagnostics

L&T Technology Services Develops NVIDIA AI-Powered Digital Twin Platform for Respiratory Diagnostics

The AI-powered digital twin platform combines LTTS’ expertise in AI-driven diagnostics and predictive analytics with cutting-edge NVIDIA AI infrastructure.

Engineering | 01/12/2025 | By Dineshwori 147

Lupin Secures US FDA Approval for Pegfilgrastim Biosimilar Armlupeg

Lupin Secures US FDA Approval for Pegfilgrastim Biosimilar Armlupeg

Lupin has received approval from the U.S. Food and Drug Administration (FDA) for its biosimilar Armlupeg (pegfilgrastim-unne), marking an important milestone in the company’s biologics journey. Armlupeg is a biosimilar to Neulasta (pegfilgrastim), a widely used therapy that helps reduce infection risk in cancer patients undergoing chemotherapy.

Engineering | 01/12/2025 | By Darshana

Sovereign Pharma Unveils India's First High-Volume Ampoule Isolator Line

Sovereign Pharma Unveils India's First High-Volume Ampoule Isolator Line

Sovereign Pharma has unveiled India’s first high-volume ampoule isolator line, a state-of-the-art solution designed to deliver enhanced sterility assurance, minimise contamination risks, and meet global regulatory standards.

Engineering | 27/11/2025 | By Dineshwori

Zydus Inks Exclusive Deal with RK Pharma for Novel Oncology Supportive Care Injectable in US

Zydus Inks Exclusive Deal with RK Pharma for Novel Oncology Supportive Care Injectable in US

Zydus Lifesciences Ltd., along with its subsidiaries and affiliates, has entered into an exclusive licensing and commercialization agreement with US-based RK Pharma Inc for a novel sterile injectable developed under the 505(b)(2) pathway for oncology supportive care in the United States.

Engineering | 26/11/2025 | By Darshana

Abbott Issues Medical Device Correction for FreeStyle Libre 3 Sensors

Abbott Issues Medical Device Correction for FreeStyle Libre 3 Sensors

Abbott has initiated a medical device correction in the United States for specific batches of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors after internal testing found that some units may deliver inaccurate low glucose readings.

Engineering | 26/11/2025 | By Darshana 139

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members